{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:57:02Z","timestamp":1762865822055},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"DOI":"10.1097\/qai.0b013e3182255dc2","type":"journal-article","created":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T19:36:40Z","timestamp":1308080200000},"page":"32-37","source":"Crossref","is-referenced-by-count":51,"title":["Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB\/HIV Patients Commencing Antiretroviral Therapy"],"prefix":"10.1097","volume":"58","author":[{"given":"William","family":"Worodria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Massinga-Loembe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Mazakpwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Luzinda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"Menten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Van Leth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"Mayanja-Kizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Kestens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy D","family":"Mugerwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Colebunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210131","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/004947559802800425","article-title":"Tuberculosis control in the face of the HIV epidemic.","volume":"28","author":"Harries","year":"1998","journal-title":"Trop Doct"},{"key":"R3-5-20210131","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.trstmh.2007.04.023","article-title":"Trends in mortality from pulmonary tuberculosis and HIV\/AIDS co-infection in rural South Africa (Agincourt).","volume":"101","author":"Zwang","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R4-5-20210131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/ajrccm.151.1.7812542","article-title":"Accelerated course of human immunodeficiency virus infection after tuberculosis.","volume":"151","author":"Whalen","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"R6-5-20210131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2334-10-83","article-title":"Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.","volume":"10","author":"Pepper","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R7-5-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"R8-5-20210131","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy.","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"R9-5-20210131","doi-asserted-by":"crossref","first-page":"566","DOI":"10.7196\/SAMJ.4434","article-title":"Prolonged deferral of antiretroviral therapy in the SAPIT trial: Did we need a clinical trial to tell us that this would increase mortality?","volume":"100","author":"Boulle","year":"2010","journal-title":"S Afr Med J"},{"key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/QAD.0b013e32833a2507","article-title":"Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.","volume":"24","author":"Komati","year":"2010","journal-title":"AIDS"},{"key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","article-title":"Survival rate and risk factors of mortality among HIV\/tuberculosis-coinfected patients with and without antiretroviral therapy.","volume":"43","author":"Manosuthi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-5-20210131","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R18-5-20210131","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/QAD.0b013e32833a2a4a","article-title":"Body mass index and risk of tuberculosis and death.","volume":"24","author":"Hanrahan","year":"2010","journal-title":"AIDS"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/01.qai.0000122708.59121.03","article-title":"Body mass index at time of HIV diagnosis: a strong and independent predictor of survival.","volume":"37","author":"van der Sande","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijid.2008.11.013","article-title":"HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.","volume":"13","author":"Kingkaew","year":"2009","journal-title":"Int J Infect Dis"},{"key":"R21-5-20210131","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0962-8479(95)90526-X","article-title":"Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis.","volume":"76","author":"Richter","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"R22-5-20210131","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3201\/eid1502.080942","article-title":"Causes of death in HIV-infected persons who have tuberculosis, Thailand.","volume":"15","author":"Cain","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"R23-5-20210131","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3201\/eid1307.061506","article-title":"Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.","volume":"13","author":"Akksilp","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R24-5-20210131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1758-2652-12-14","article-title":"Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV.","volume":"12","author":"Tabarsi","year":"2009","journal-title":"J Int AIDS Soc"},{"key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2458-10-177","article-title":"Low HIV testing rates among tuberculosis patients in Kampala, Uganda.","volume":"10","author":"Sendagire","year":"2010","journal-title":"BMC Public Health"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2471\/BLT.07.042580","article-title":"Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals.","volume":"86","author":"Wanyenze","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10461-006-9180-9","article-title":"Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda.","volume":"11","author":"Nakanjako","year":"2007","journal-title":"AIDS Behav"},{"key":"R29-5-20210131","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-3156.2009.02290.x","article-title":"The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.","volume":"14","author":"Cornell","year":"2009","journal-title":"Trop Med Int Health"},{"key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.","volume":"22","author":"Murdoch","year":"2008","journal-title":"AIDS"},{"key":"R31-5-20210131","first-page":"1053","article-title":"Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.","volume":"38","author":"Tansuphasawadikul","year":"2007","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R32-5-20210131","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","article-title":"Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.","volume":"21","author":"Lawn","year":"2007","journal-title":"AIDS"},{"key":"R33-5-20210131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.","volume":"10","author":"Muller","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R34-5-20210131","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.","volume":"12","author":"Liechty","year":"2007","journal-title":"Trop Med Int Health"},{"key":"R35-5-20210131","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count or = 1 100 cells\/microL who start HIV therapy in resource-limited settings.","volume":"51","author":"Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R36-5-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-3156.2009.02291.x","article-title":"Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi.","volume":"14","author":"Zachariah","year":"2009","journal-title":"Trop Med Int Health"},{"key":"R37-5-20210131","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2334-8-52","article-title":"Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania.","volume":"8","author":"Johannessen","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R38-5-20210131","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4269\/ajtmh.2006.74.154","article-title":"Delayed-type hypersensitivity skin test reactivity and survival in HIV-infected patients in Uganda: should anergy be a criterion to start antiretroviral therapy in low-income countries?","volume":"74","author":"Jones-Lopez","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"R39-5-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s15010-007-6090-3","article-title":"Clinical predictors for death in HIV-positive and HIV-negative tuberculosis patients in Guinea-Bissau.","volume":"35","author":"Gustafson","year":"2007","journal-title":"Infection"},{"key":"R40-5-20210131","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ije\/27.4.703","article-title":"CD4+ lymphocytes and tuberculin skin test as survival predictors in pulmonary tuberculosis HIV-infected patients.","volume":"27","author":"Serrat","year":"1998","journal-title":"Int J Epidemiol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201109010-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:29:27Z","timestamp":1618039767000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201109010-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3182255dc2","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}